CONCLUSION
ADVERSE REACTIONS
PISEI may be related to suppressing of blood oxygen metabolism and functional activities in DLPFC, PMC, and SM1 brain regions. fNIRS, based on dynamic monitoring of hemodynamics, can be used as an auxiliary tool for prompt screening and diagnosis of PISEI. A single TMS session was favorable for PISEI patients, and the efficacy lasted up to 3 days, which may be associated with the activation of left DLPFC, right PMC, and right SM1 brain regions and the enhanced synergism of neural remodeling. The TMS stimulation parameters and treatment environment in our study did not provoke adverse reactions in the subjects, and the safety of the above treatment conditions was controllable under the specific conditions in this research. In future work, randomized controlled trials with large samples, multi‐centers, and follow‐up sessions should be carried out, and systematic and varied behavioral evaluation indicators should be adopted to comprehensively validate the exact efficacy of TMS on PISEI.